Basit öğe kaydını göster

dc.contributor.authorHalise Inci, Gul
dc.contributor.authorParham, Taslimi
dc.contributor.authorIlhami, Gulcin
dc.contributor.authorClaudiu T., Supuran
dc.date.accessioned2019-05-17T07:27:13Z
dc.date.available2019-05-17T07:27:13Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/11772/1188
dc.description.abstract4-(3-(4-Substituted-phenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl) benzenesulfonamides (9-16) were successfully synthesized and their chemical structures were confirmed by H-1 NMR, C-13 NMR, and HRMS spectra. Carbonic anhydrase I and II inhibitory effects of the compounds were investigated. Ki values of the compounds were in the range of 316.7 +/- 9.6-533.1 +/- 187.8nM towards hCA I and 412.5 +/- 115.4-624.6 +/- 168.2nM towards hCA II isoenzymes. While K-i values of the reference compound Acetazolamide were 278.8 +/- 44.3 nM and 293.4 +/- 46.4 nM towards hCA I and hCA II izoenzymes, respectively. Compound 14 with bromine and compound 13 with fluorine substituents can be considered as the leader compounds of the series because of the lowest K-i values in series to make further detailed carbonic anhydrase inhibiton studies.en_US
dc.language.isoengen_US
dc.publisherInformaen_US
dc.relation.isversionof10.1080/14756366.2016.1244533en_US
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_US
dc.subjectCarbonic anhydraseen_US
dc.subjectEnzymeen_US
dc.subjectPyrazolineen_US
dc.subjectSulfonamideen_US
dc.titleSynthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolinesen_US
dc.typearticleen_US
dc.relation.journalJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.contributor.departmentBartın Üniversitesi, Fen Fakültesi, Biyoteknoloji Bölümüen_US
dc.identifier.volume32en_US
dc.identifier.issue1en_US
dc.identifier.startpage189en_US
dc.identifier.endpage192en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster